Acumen Pharmaceuticals, Inc. Company Profile
Acumen Pharmaceuticals, Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, Massachusetts, 02465, United States.
- Mailing address: Value 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, Massachusetts, 02465, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, Massachusetts, 02465, United States |
| Mailing address | 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, Massachusetts, 02465, United States |
| Industry (SIC) | 2836 Biological Products, (No Diagnostic Substances) |
| Fiscal year end | 12-31 |
| Filer category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| Listed stock (Section 12(b)) | Common stock, par value $0.0001 per share · ABOS · The Nasdaq Global Select Market 10-Q filed 2026-08-12 cover |
| Shell company | No 10-Q filed 2026-08-12 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-12 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-12 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-12 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-26 cover |
| Voluntary filer | No 10-K filed 2026-03-26 cover |
| First EDGAR filing | 2013-05-15 (D) |
| SEC CIK | 1576885 |
| EIN | 364108129 |
| Phone | 617-344-4190 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |